USOR 20289_Seagen | Maryland Oncology Hematology

USOR 20289_Seagen

Trial Information

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

Learn More at ClinicalTrials.gov

Sponsor: Seattle Genetics, Inc.

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Multiple

Investigator

Wallmark

Sponsor

Seattle Genetics, Inc.

« Clinical Trails Main

Quality Care Close to Home

View our locations on map!